MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Eisai-Biogen

  • FDA Advisers to Weigh Full Approval for Eisai-Biogen’s Alzheimer’s Drug
    FDA Advisers to Weigh Full Approval for Eisai-Biogen’s Alzheimer’s Drug
    The Food and Drug Administration (FDA) plans to hold a meeting of its outside experts in June to discuss full approval of the Alzheimer's drug developed by Eisai Co. Ltd. ...
    April 11, 2023BY Reuters
TOP NEWS
  • Trump Says He’s Considering Whether US Should Join Saudi Attacks Against Houthis
    NEW By Jack Phillips
    Trump Says He’s Considering Whether US Should Join Saudi Attacks Against Houthis
  • Saudi Arabia Reports New Airport Attacks After Deadly Strike
    NEW By Jacki Thrapp
    Saudi Arabia Reports New Airport Attacks After Deadly Strike
  • Trump: Russia and Ukraine Agree to ‘Energy Ceasefire’
    5hr By Emel Akan
    Trump: Russia and Ukraine Agree to ‘Energy Ceasefire’
  • Pope Leo to Undergo Surgery After Doctors Find Nodule in Lung
    7hr By Jacki Thrapp
    Pope Leo to Undergo Surgery After Doctors Find Nodule in Lung
  • AVs Drive More Safely—but Can Lead Nearby Human Drivers to Take Risks: Study
    8hr By Jeremy Lott
    AVs Drive More Safely—but Can Lead Nearby Human Drivers to Take Risks: Study
  • Nearly 15,000 ICE Detainers Not Honored in New York City, DHS Says
    10hr By Naveen Athrappully
    Nearly 15,000 ICE Detainers Not Honored in New York City, DHS Says
  • We Went Into a Narco-Tunnel With the Elite ‘Tunnel Rats’
    12hr By Brad Jones
    We Went Into a Narco-Tunnel With the Elite ‘Tunnel Rats’
  • London Mansion Linked to China’s Evergrande Group Founder Lies Abandoned
    12hr By Michael Zhuang
    London Mansion Linked to China’s Evergrande Group Founder Lies Abandoned
  • 12 Killed, More Than 300 Wounded in Terror Attack on Saudi International Airport
    17hr By Melanie Sun
    12 Killed, More Than 300 Wounded in Terror Attack on Saudi International Airport
  • Trump Speaks at Rally for Tennessee Republicans
    18hr By Jacki Thrapp
    Trump Speaks at Rally for Tennessee Republicans
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top